Metis TechBio and Eli Lilly Form Discovery Collaboration Potentially Worth Over $1 Billion
The companies will work to discover lipid nanoparticle-based delivery solutions designed to enable tissue-specific delivery.
Metis TechBio has entered into a collaboration with Eli Lilly that could be worth more than 1 billion to the Hong Kong-listed biotechnology company. Metis said Monday that the companies will work together to discover novel lipid nanoparticle-based delivery solutions intended to enable tissue-specific…